SANUWAVE Health, Inc. provided earnings guidance for the First Quarter 2024. For the period, the company expects revenues to be in the range of $5.7 million to $5.9 million, an increase of 51% to 56% over First Quarter 2023 and consistent with the high end of the range of guidance given in the Company?s Fourth Quarter 2023 earnings release from March 22, 2024.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.018 USD | 0.00% | -18.18% | +38.46% |
Apr. 10 | Sanuwave Health, Inc. Provides Earnings Guidance for the First Quarter 2024 | CI |
Apr. 01 | SANUWAVE Health, Inc. Appoints Peter Sorensen as CFO | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+38.46% | 20.53M | |
-3.49% | 184B | |
-2.35% | 107B | |
-3.92% | 67.78B | |
+2.12% | 50.66B | |
+10.55% | 47.64B | |
+4.60% | 41.12B | |
+2.17% | 26.3B | |
+1.62% | 26.04B | |
+15.06% | 25.4B |
- Stock Market
- Equities
- SNWV Stock
- News SANUWAVE Health, Inc.
- Sanuwave Health, Inc. Provides Earnings Guidance for the First Quarter 2024